Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 7.86B P/E 32.94 EPS this Y 16.20% Ern Qtrly Grth 32.80%
Income 300.92M Forward P/E 23.44 EPS next Y 8.00% 50D Avg Chg -3.00%
Sales 2.34B PEG 2.26 EPS past 5Y 9.72% 200D Avg Chg 1.00%
Dividend N/A Price/Book 8.25 EPS next 5Y 11.25% 52W High Chg -9.00%
Recommedations 1.30 Quick Ratio 1.56 Shares Outstanding 15M 52W Low Chg 22.00%
Insider Own 2.12% ROA 14.13% Shares Float 14.73M Beta 0.44
Inst Own 98.10% ROE 27.87% Shares Shorted/Prior 238.50K/249.79K Price 523.07
Gross Margin 35.97% Profit Margin 12.88% Avg. Volume 73,159 Target Price 685.00
Oper. Margin 14.79% Earnings Date Oct 29 Volume 93,254 Change 0.40%
About Chemed Corp

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

Chemed Corp News
11/08/24 Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 50 Cents
11/05/24 Chemed Corporation to Present at the UBS 2024 Global Healthcare Conference
11/04/24 AMED or CHE: Which Is the Better Value Stock Right Now?
11/01/24 Analyst Estimates: Here's What Brokers Think Of Chemed Corporation (NYSE:CHE) After Its Third-Quarter Report
10/31/24 We Ran A Stock Scan For Earnings Growth And Chemed (NYSE:CHE) Passed With Ease
10/31/24 Chemed Third Quarter 2024 Earnings: EPS Misses Expectations
10/31/24 Chemed Corp (CHE) Q3 2024 Earnings Call Highlights: VITAS Shines Amid Roto-Rooter's Challenges
10/31/24 Q3 2024 Chemed Corp Earnings Call
10/30/24 CHE Misses on Q3 Earnings, Lowers '24 EPS View, Stock Up
10/29/24 Chemed (CHE) Lags Q3 Earnings and Revenue Estimates
10/29/24 Chemed: Q3 Earnings Snapshot
10/29/24 Chemed Reports Third-Quarter 2024 Results
10/16/24 AMED vs. CHE: Which Stock Is the Better Value Option?
10/08/24 Reasons to Retain Chemed Stock in Your Portfolio Now
09/28/24 Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future
09/18/24 Why Chemed (CHE) is a Top Growth Stock for the Long-Term
09/13/24 Chemed To Report Third-Quarter 2024 Earnings October 29, Related Conference Call To Be Held On October 30
09/11/24 Here’s Why Chemed Corporation (CHE) Declined in Q2
09/10/24 Insider Sale: Executive Vice President Nicholas Westfall Sells Shares of Chemed Corp (CHE)
09/02/24 Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
CHE Chatroom

User Image Milanfinest Posted - 1 week ago

$CHE hello

User Image Stocksrunner Posted - 10/30/24

🌟 Curious about the buzz in the market today? Let's just say a few stocks are catching some serious attention. Keep an eye on $BDX $CHE $CL $DAR and $LEVI—they're the ones everyone's whispering about. Want to know more? You'll just have to stick around. 😉 https://stocksrunner.com/posts/1317

User Image chopchop0 Posted - 10/30/24

$CHE anyone buying? Great businesses

User Image Estimize Posted - 10/28/24

Wall St is expecting 8.27% YoY EPS growth for $CHE in Q3, down from 16.14% in Q2 [Reporting Tomorrow 10/29 AMC] http://www.estimize.com/int

User Image WeeklyTrader Posted - 1 month ago

What’s your exit plan for $CHE? RSI: 53.35% 50-day MA: $580.75 200-day MA: $582.41

User Image WeeklyTrader Posted - 1 month ago

What’s your take on $CHE soaring?

User Image insiderbuyingselling Posted - 09/27/24

$CHE new insider selling: 2000 shares. http://insiderbuyingselling.com/?t=CHE

User Image StockInvest_us Posted - 09/25/24

Signal alert: $CHE - Double Bottom https://stockinvest.us/l/lBfWCsmJwf

User Image StockInvest_us Posted - 09/24/24

Signal alert: $CHE - Double Bottom https://stockinvest.us/l/gmaP9Es1bM

User Image Stock_Titan Posted - 2 months ago

$CHE Chemed To Report Third-Quarter 2024 Earnings October 29, Related Conference Call To Be Held On October 30 https://www.stocktitan.net/news/CHE/chemed-to-report-third-quarter-2024-earnings-october-29-related-cx8wku1n15t4.html

User Image Stocksrunner Posted - 08/29/24

Technical Signals Flashing Across Sectors: $CHE crosses above its 200-day MA $KO hits a new 52-week high $HCC shows bullish signs $INTA jumps to a new high and $GMS drops below support. https://stocksrunner.com/posts?id=1092

User Image insiderbuyingselling Posted - 3 months ago

$CHE new insider selling: 4827 shares. http://insiderbuyingselling.com/?t=CHE

User Image insiderbuyingselling Posted - 3 months ago

$CHE new insider selling: 2000 shares. http://insiderbuyingselling.com/?t=CHE

User Image onlythebestcompanies Posted - 3 months ago

$CHE $750 soon.

User Image NVDAMillionaire Posted - 07/30/24

$CHE Chemed Corporation (NYSE:CHE) – A Comprehensive Look at the Leading Provider of Hospice and Plumbing Services http://beyondspx.com/2024/07/28/chemed-corporation-nyseche-a-comprehensive-look-at-the-leading-provider-of-hospice-and-plumbing-services/

User Image StockInvest_us Posted - 07/24/24

Signal alert: $CHE - PivotPoint bottom https://stockinvest.us/l/MQLPgOZoGM

User Image DonCorleone77 Posted - 07/24/24

$CHE Chemed raises FY24 adjusted EPS view to $23.55-$23.80 from $23.30-$23.70 Chemed said: "VITAS 2024 revenue, prior to Medicare Cap, is estimated to increase 16.3% to 17.3% when compared to 2023. ADC is estimated to increase 13.3% to 14.4%. Full year adjusted EBITDA margin, prior to Medicare Cap, is estimated to be 19.3% to 19.7%. We are currently estimating $8.5 million in Medicare Cap billing limitations in calendar 2024. The cost of the retention program negatively impacted VITAS' 2023 full year adjusted EBITDA by 159 basis points. Covenant Health is estimated to contribute approximately $30 million to $32 million of revenue to VITAS' full year revenue. There is no estimated Medicare Cap billing limitation expected related to Covenant Health. This translates into adjusted net income attributable to Covenant Health of $5.5 million to $6.0 million and adjusted EBITDA of $8.0 million to $8.5 million. Roto-Rooter is forecasted to have a 4.0% to 5.0% revenue decline in 2024 compared to 2023. Roto-Rooter's adjusted EBITDA margin for 2024 is expected to be 26.5% to 27.0%."

User Image DonCorleone77 Posted - 07/24/24

$CHE Chemed reports Q2 adjusted EPS $5.47, consensus $5.59 Reports Q2 revenue $595.88, consensus $599.19M.

User Image epsguid Posted - 07/24/24

$CHE reported earnings of $5.47, consensus was $5.14 via @eWhispers #epsbeat http://eps.sh/d/che

User Image Stock_Titan Posted - 07/24/24

$CHE Chemed Reports Second-Quarter 2024 Results https://www.stocktitan.net/news/CHE/chemed-reports-second-quarter-2024-y96i2l1f292t.html

User Image Stock_Titan Posted - 4 months ago

$CHE Chemed To Report Second-Quarter 2024 Earnings July 24, Related Conference Call To Be Held On July 25 https://www.stocktitan.net/news/CHE/chemed-to-report-second-quarter-2024-earnings-july-24-related-fy4dk1mckf3p.html

User Image Doctor_Cheese Posted - 05/22/24

$CHE feeling like im only one trading this thing

User Image InsiderPeek Posted - 6 months ago

$CHE CEO McNamara Kevin J sold 4k shares for $2.3 millions (ownership down 3.55%) insiderpeek.com/company/CHE

User Image StockInvest_us Posted - 6 months ago

Signal alert: $CHE - Oversold Trend Short (Undervalued) https://stockinvest.us/l/EOhrWuKdcb

User Image StockInvest_us Posted - 04/24/24

Signal alert: $CHE - GoldenStar https://stockinvest.us/l/DzZACCi9U2

User Image StockInvest_us Posted - 04/24/24

Signal alert: $CHE - PivotPoint bottom https://stockinvest.us/l/D3mEziReCO

User Image DonCorleone77 Posted - 04/24/24

$CHE Chemed reports Q1 adjusted EPS $5.20, consensus $5.48 Reports Q1 revenue $589.23M, consensus $591.46M.

User Image epsguid Posted - 04/24/24

$CHE reported earnings of $5.20, consensus was $5.09 via @eWhispers #epsbeat http://eps.sh/d/che

User Image Stock_Titan Posted - 04/24/24

$CHE Chemed Reports First-Quarter 2024 Results https://www.stocktitan.net/news/CHE/chemed-reports-first-quarter-2024-0qh4jkwmixx9.html

User Image StockInvest_us Posted - 7 months ago

Signal alert: $CHE - GoldenStar https://stockinvest.us/l/dpNmeANpi5

Analyst Ratings
RBC Capital Outperform May 21, 24
RBC Capital Outperform Mar 4, 24
Oppenheimer Outperform Feb 29, 24
Oppenheimer Outperform Jan 17, 24
RBC Capital Outperform Oct 30, 23
RBC Capital Outperform Jul 31, 23
Oppenheimer Outperform Jul 27, 23
RBC Capital Outperform May 1, 23
Oppenheimer Outperform Apr 28, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
MCNAMARA KEVIN J president and CEO president and CEO Dec 11 Sell 572.77 1,500 859,155 111,468 12/13/23
LEE SPENCER S executive vice presi.. executive vice president Nov 27 Sell 579.73 1,000 579,730 22,568 11/27/23
WILLIAMS DAVID PATRICK executive vice presi.. executive vice president & CFO Nov 10 Sell 580.79 5,000 2,903,950 10,826 11/13/23
LEE SPENCER S executive vice presi.. executive vice president Nov 07 Sell 583.85 1,217 710,545 23,633 11/08/23
WILLIAMS DAVID PATRICK executive vice presi.. executive vice president & CFO Nov 07 Sell 583.85 6,000 3,503,100 15,826 11/08/23
MCNAMARA KEVIN J president and CEO president and CEO Aug 03 Sell 516.43 4,000 2,065,720 115,571 08/07/23
MCNAMARA KEVIN J president and CEO president and CEO Aug 03 Option 413.19 3,000 1,239,570 118,571 08/07/23
MCNAMARA KEVIN J president and CEO president and CEO May 02 Option 413.19 3,500 1,446,165 122,113 05/02/23
MCNAMARA KEVIN J president and CEO president and CEO Mar 28 Sell 526.27 3,000 1,578,810 118,613 03/29/23
WILLIAMS DAVID PATRICK executive vice presi.. executive vice president & CFO Mar 20 Sell 523.25 4,000 2,093,000 20,443 03/21/23
MCNAMARA KEVIN J president and CEO president and CEO Mar 09 Sell 507.32 2,000 1,014,640 121,613 03/10/23
LEE SPENCER S executive vice presi.. executive vice president Nov 08 Sell 490.09 2,000 980,180 22,701 11/08/22
MCNAMARA KEVIN J president and CEO president and CEO Nov 03 Option 306.7 5,000 1,533,500 123,264 11/04/22
MCNAMARA KEVIN J president and CEO president and CEO Nov 03 Sell 482.9 2,000 965,800 122,235 11/04/22
Witzeman Michael D vice president and c.. vice president and controller Nov 03 Option 306.7 6,900 2,116,230 8,086 11/04/22
Witzeman Michael D vice president and c.. vice president and controller Nov 03 Sell 482.62 1,300 627,406 1,186 11/04/22
MCNAMARA KEVIN J president and CEO president and CEO Sep 13 Sell 474.13 2,000 948,260 124,235 09/14/22
MCNAMARA KEVIN J president and CEO president and CEO Aug 18 Sell 481.93 3,000 1,445,790 125,185 08/22/22
MCNAMARA KEVIN J president and CEO president and CEO Aug 18 Option 306.7 5,000 1,533,500 130,185 08/22/22
GRACE PATRICK P Director Director Jun 10 Sell 465.47 262 121,953 3,270 06/13/22
Westfall Nicholas Michael Executive Vice Presi.. Executive Vice President May 10 Sell 500.10 1,432 716,143 7,000 05/11/22
MCNAMARA KEVIN J president and CEO president and CEO May 10 Sell 502.00 2,000 1,004,000 128,185 05/11/22
WILLIAMS DAVID PATRICK executive vice presi.. executive vice president & CFO May 06 Option 231.91 20,000 4,638,200 48,729 05/06/22
WILLIAMS DAVID PATRICK executive vice presi.. executive vice president & CFO May 06 Sell 500.38 4,000 2,001,520 30,856 05/06/22
MCNAMARA KEVIN J president and CEO president and CEO May 02 Option 306.7 10,000 3,067,000 138,048 05/04/22
MCNAMARA KEVIN J president and CEO president and CEO May 02 Sell 486.79 3,000 1,460,370 128,048 05/04/22
SAUNDERS DONALD E Director Director Apr 07 Sell 521.23 405 211,098 5,331 04/14/22
MCNAMARA KEVIN J president and CEO president and CEO Mar 08 Option 306.7 10,000 3,067,000 142,021 03/09/22
MCNAMARA KEVIN J president and CEO president and CEO Mar 08 Sell 469.91 3,000 1,409,730 131,048 03/09/22
LEE SPENCER S executive vice presi.. executive vice president Mar 07 Sell 487.39 1,054 513,709 24,701 03/08/22
WILLIAMS DAVID PATRICK executive vice presi.. executive vice president & CFO Feb 18 Option 459.77 2,132 980,230 29,662 02/23/22
Westfall Nicholas Michael Executive Vice Presi.. Executive Vice President Feb 18 Option 459.77 1,592 731,954 9,070 02/23/22
MCNAMARA KEVIN J president and CEO president and CEO Feb 18 Option 459.77 8,220 3,779,309 135,692 02/23/22
Westfall Nicholas Michael Executive Vice Presi.. Executive Vice President Jun 10 Option 231.91 3,771 874,533 4,770 06/10/21
Westfall Nicholas Michael Executive Vice Presi.. Executive Vice President Jun 10 Sell 485.04 2,708 1,313,488 999 06/10/21
Witzeman Michael D vice president and c.. vice president and controller Nov 05 Option 231.91 8,000 1,855,280 12,001 11/05/20
Witzeman Michael D vice president and c.. vice president and controller Nov 05 Sell 514.73 1,000 514,730 11,001 11/05/20